MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell

Jing Wen1,2, Jianhua Fu2,3, Yihong Ling2,4

  • 1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Oncotarget
|January 30, 2016
PubMed

Insights

Migration and invasion inhibitory protein (MIIP) reduces epidermal growth factor receptor (EGFR) protein levels in lung cancer cells, inhibiting proliferation. Higher MIIP expression correlates with better survival in lung adenocarcinoma patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The migration and invasion inhibitory protein (MIIP) is a recently identified protein with roles in inhibiting cell proliferation and migration.
  • Epidermal growth factor receptor (EGFR) is a key regulator of cell growth and is often dysregulated in cancer.

Purpose of the Study:

  • To elucidate the mechanism by which MIIP inhibits cell proliferation.
  • To investigate the relationship between MIIP and EGFR in lung cancer.

Main Methods:

  • Overexpression of MIIP in lung cancer cells.
  • Assessment of EGFR protein and mRNA levels.
  • Use of proteasome and lysosome inhibitors.
  • Pulse-chase experiments with 35S-methionine.
  • Analysis of clinical lung adenocarcinoma samples.

Main Results:

  • MIIP overexpression decreased EGFR protein levels without affecting EGFR mRNA, indicating post-transcriptional regulation.
  • EGFR degradation was mediated by both proteasomal and lysosomal pathways, involving ER and endocytic trafficking.
  • MIIP-induced EGFR downregulation inhibited Ras/MEK signaling, leading to reduced cell proliferation.
  • A negative correlation between MIIP and EGFR protein expression was observed in lung adenocarcinoma.
  • High MIIP expression predicted better survival in Stage IA-IIIA lung adenocarcinoma patients.

Conclusions:

  • MIIP inhibits lung cancer cell proliferation by promoting EGFR protein degradation through both proteasomal and lysosomal pathways.
  • MIIP serves as a potential prognostic biomarker for improved survival in lung adenocarcinoma patients.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K